JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Marala, R. B.
Right arrow Articles by Mustafa, S. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Marala, R. B.
Right arrow Articles by Mustafa, S. J.

Vol. 286, Issue 2, 1051-1057, August 1998

Immunological Characterization of Adenosine A2A Receptors in Human and Porcine Cardiovascular Tissues1

Ravi B. Marala2 and S. Jamal Mustafa

Department of Pharmacology, School of Medicine, East Carolina University, Greenville, North Carolina

Antipeptide antibody was raised in rabbit against the sequence (361-390) of RDC-8, the presumed adenosine A2A receptor cDNA from canine. The antibody titer was estimated by solid phase radioimmunoassay. Western blot analysis under reducing conditions identified a major 45 ± 1 kDa protein in bovine striatal membranes. This immunoreactive band was competed in the presence of excess peptide. Furthermore, the antibody recognized a single 45-kDa immunoreactive band in membranes from cells transfected with the recombinant human adenosine A2A receptors, whereas, fail to cross-react with membranes from cells transfected with recombinant rat A1 and human A3 receptors. Membranes from human and porcine coronary artery, ventricle, atria and platelets (human only) showed a major immunoreactive band at 45 ± 1 kDa size. Under nonreducing conditions, the migration patterns of the immunoreactive bands were not altered indicating the absence of interchain disulfide bond. The 45-kDa immunoreactive band co-migrated with 2-[4-(2-{2-[(4-aminophenyl)methylcarbonylamino]ethyl-aminocarbonyl}ethyl)phenyl]ethylamino-5'-Nethylcarboxamidoadenosine photoaffinity labeled A2A adenosine receptor using SANPAH as the photoaffinity cross-linker. We provide immunological evidence for the presence of A2A adenosine receptor in human cardiovascular tissues that exists as a 45-kDa monomeric protein. This study also presents evidence for the presence of A2A adenosine receptor in ventricle and atria in both human and porcine.


0022-3565/98/2862-1051$03.00/0
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Copyright © 1998 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
A. Nadeem, M. Fan, H. R. Ansari, C. Ledent, and S. Jamal Mustafa
Enhanced airway reactivity and inflammation in A2A adenosine receptor-deficient allergic mice
Am J Physiol Lung Cell Mol Physiol, June 1, 2007; 292(6): L1335 - L1344.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
S. J. Rayment, V. Ralevic, D. A. Barrett, R. Cordell, and S. P. H. Alexander
A novel mechanism of vasoregulation: ADP-induced relaxation of the porcine isolated coronary artery is mediated via adenosine release
FASEB J, February 1, 2007; 21(2): 577 - 585.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
R. D. Lasley, G. Kristo, B. J. Keith, and R. M. Mentzer Jr.
The A2a/A2b receptor antagonist ZM-241385 blocks the cardioprotective effect of adenosine agonist pretreatment in in vivo rat myocardium
Am J Physiol Heart Circ Physiol, January 1, 2007; 292(1): H426 - H431.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
B. Teng, H. R. Ansari, P. J. Oldenburg, J. Schnermann, and S. J. Mustafa
Isolation and characterization of coronary endothelial and smooth muscle cells from A1 adenosine receptor-knockout mice
Am J Physiol Heart Circ Physiol, April 1, 2006; 290(4): H1713 - H1720.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
B. Teng, W. Qin, H. R. Ansari, and S. J. Mustafa
Involvement of p38-mitogen-activated protein kinase in adenosine receptor-mediated relaxation of coronary artery
Am J Physiol Heart Circ Physiol, June 1, 2005; 288(6): H2574 - H2580.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
Z. Yang, Y.-J. Day, M.-C. Toufektsian, S. I. Ramos, M. Marshall, X.-Q. Wang, B. A. French, and J. Linden
Infarct-Sparing Effect of A2A-Adenosine Receptor Activation Is Due Primarily to Its Action on Lymphocytes
Circulation, May 3, 2005; 111(17): 2190 - 2197.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. P. Headrick, B. Hack, and K. J. Ashton
Acute adenosinergic cardioprotection in ischemic-reperfused hearts
Am J Physiol Heart Circ Physiol, November 1, 2003; 285(5): H1797 - H1818.
[Abstract] [Full Text] [PDF]


Home page
Card Surg AdultHome page
R. M. Mentzer Jr., M. S. Jahania, and R. D. Lasley
Myocardial Protection
Card. Surg. Adult, January 1, 2003; 2(2003): 413 - 438.
[Full Text]


Home page
Am. J. Physiol. Renal Physiol.Home page
E. K. Jackson, C. Zhu, and S. P. Tofovic
Expression of adenosine receptors in the preglomerular microcirculation
Am J Physiol Renal Physiol, July 1, 2002; 283(1): F41 - F51.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
R. D. Lasley, M. S. Jahania, and R. M. Mentzer Jr.
Beneficial effects of adenosine A2a agonist CGS-21680 in infarcted and stunned porcine myocardium
Am J Physiol Heart Circ Physiol, April 1, 2001; 280(4): H1660 - H1666.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
H. A. Olanrewaju, W. Qin, I. Feoktistov, J.-L. Scemama, and S. J. Mustafa
Adenosine A2A and A2B receptors in cultured human and porcine coronary artery endothelial cells
Am J Physiol Heart Circ Physiol, August 1, 2000; 279(2): H650 - H656.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
T. W. Hein, L. Belardinelli, and L. Kuo
Adenosine A2A Receptors Mediate Coronary Microvascular Dilation to Adenosine: Role of Nitric Oxide and ATP-Sensitive Potassium Channels
J. Pharmacol. Exp. Ther., November 1, 1999; 291(2): 655 - 664.
[Abstract] [Full Text]


Home page
Mol. Pharmacol.Home page
Z. Nie, Y. Mei, R. L. Malek, A. Marcuzzi, N. H. Lee, and V. Ramkumar
A Role of p75 in NGF-Mediated Down-Regulation of the A2A Adenosine Receptors in PC12 Cells
Mol. Pharmacol., November 1, 1999; 56(5): 947 - 954.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
R. R. Morrison, M. A. H. Talukder, C. Ledent, and S. J. Mustafa
Cardiac effects of adenosine in A2A receptor knockout hearts: uncovering A2B receptors
Am J Physiol Heart Circ Physiol, February 1, 2002; 282(2): H437 - H444.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
E. L. Kilpatrick, P. Narayan, R. M. Mentzer Jr., and R. D. Lasley
Cardiac myocyte adenosine A2a receptor activation fails to alter cAMP or contractility: role of receptor localization
Am J Physiol Heart Circ Physiol, March 1, 2002; 282(3): H1035 - H1040.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1998 by the American Society for Pharmacology and Experimental Therapeutics.